Editorial
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Med Genet. Feb 27, 2014; 4(1): 1-5
Published online Feb 27, 2014. doi: 10.5496/wjmg.v4.i1.1
Genetic counseling in post-genomic era: Don’t pretend to know the meaning of a gene mutation if you don’t know
Liting Song
Liting Song, Hope Biomedical Research, Toronto, ON M2K 2J8, Canada
Author contributions: Song L solely contributed to this paper.
Correspondence to: Liting Song, MD, MSc, Scientist, Hope Biomedical Research, 809-50 Ruddington Drive, Toronto, ON M2K 2J8, Canada. ltsong@yahoo.com
Telephone: +1-416-7331573 Fax: +1-416-7331573
Received: June 13, 2013
Revised: August 23, 2013
Accepted: December 12, 2013
Published online: February 27, 2014
Processing time: 256 Days and 22.2 Hours
Abstract

In this post-genomic era, more and more susceptibility loci of many possible genetic diseases are published. As our knowledge about these susceptibility loci is limited and partial, we should be very careful and responsible when patients seek genetic counseling about these possible genetic diseases. We should apply Confucius’s principle about knowledge and information to genetic conseling, and tell the truth to our patients about what we know and what we do not know. Like many other cancers, breast cancer is a very complicated, multifactorial disease; genetic factors, lifestyles and eating habits, environmental factors, and viral infections might be involved in breast cancer; hence, it is difficult to figure out the real etiology of breast cancer. It is not crystal clear that a person who carries mutations of the breast cancer 1, early onset and/or breast cancer 2, early onset genes would eventually get breast cancer in her/his lifetime. No person should undergo a preventive double mastectomy, unless we know the etiology of breast cancer someday.

Keywords: Genetic counseling; Genetic disease; Susceptibility loci; Breast cancer 1, early onset and breast cancer 2, early onset genes; Preventive double mastectomy

Core tip: Many susceptibility loci of possible genetic diseases are published. As our knowledge about these susceptibility loci is limited and partial, we should be very careful and responsible when patients seek genetic counseling about these possible genetic diseases. Currently, I have not seen any solid evidence in support of the linkage between breast cancer and breast cancer 1, early onset (BRCA1) or/and breast cancer 2, early onset (BRCA2); and it is not crystal clear that a person who carries mutations of the BRCA1 and/or BRCA2 genes would eventually get breast cancer in her/his lifetime. No person should undergo a preventive double mastectomy, unless we know the etiology of breast cancer someday.